6-tetra-O-actyl-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydrofu-ran-3-yl]oxy] phenyl]

Alaabtani waa kiniin huruud ah oo khafiif ah oo dahaarka leh, caddaan ama ku dhawaad ​​cad ka dib markii laga saaro daahan.

Tilmaamaha
Alaabtani waxay ku habboon tahay daawaynta nooca 2aad ee sonkorowga.

monotherapy
Alaabtan waxa lala isticmaalaa xakamaynta cuntada iyo jimicsiga si loo hagaajiyo xakamaynta sonkorta dhiigga ee bukaanka qaba nooca 2 ee sonkorowga.

Waxaa loo isticmaalaa in lagu daro metformin hydrochloride
Marka metformin hydrochloride keligiis uusan si wax ku ool ah u xakameyn karin sonkorta dhiigga, badeecadan waxaa loo isticmaali karaa in lagu daro metformin hydrochloride si loo hagaajiyo xakameynta sonkorta dhiigga bukaanka qaba nooca 2 ee sonkorowga iyadoo lagu saleynayo cuntada iyo jimicsiga.

Waxaa loo isticmaalaa in lagu daro metformin hydrochloride iyo sulfonylureas.
Marka la isku daro isticmaalka metformin hydrochloride iyo sulfonylureas aysan si wax ku ool ah u xakameyn karin sonkorta dhiigga, alaabtan waxaa loo isticmaali karaa in lagu daro metformin hydrochloride iyo sulfonylureas si loo hagaajiyo xakamaynta sonkorta dhiigga ee bukaanka qaba nooca 2 ee sonkorowga iyadoo lagu saleynayo cuntada iyo jimicsiga.

Xayiraadaha daawada
Alaabtan laguma talinayo bukaanka nooca 1-aad ee sonkorowga ama daawaynta ketoacidosis-ka macaanka.

Tilmaamid
(1) 10 mg;(2) 25 mg.

Qiyaasta
Qiyaasta lagu taliyay
Qiyaasta lagu taliyey ee alaabtani waa 10 mg subaxdii, hal mar maalintii, calool madhan ama cuntada ka dib.Bukaannada u dulqaata alaabtan, qiyaasta waxaa lagu kordhin karaa 25 mg (eeg [Tijaabooyin Caafimaad]).
Bukaannada qaba hypovolemia, waxaa lagula talinayaa in la saxo hypovolemia ka hor inta aan la bilaabin isticmaalka alaabtan (eeg [Taxadirrada]).

Bukaanka qaba cillad kelyaha.
Waxaa lagu talinayaa in la qiimeeyo shaqada kelyaha ka hor inta aanad bilaabin isticmaalka alaabtan, ka dibna waa in si joogto ah loo qiimeeyaa.
Bukaannada eGFR ay ka hooseeyaan 45 ml/min/1.73 m2 waa in aanay isticmaalin alaabtan.
Bukaanka leh eGFR ka sarreeya ama la mid ah 45 mL/min/1.73 m2 uma baahna inay hagaajiyaan qiyaasta.
Haddii eGFR uu si joogto ah uga hooseeyo 45 mL/min/1.73 m2, alaabtan waa in la joojiyaa (eeg [Taxadir]).

Bukaanka qaba dhaawaca beerka.
Bukaanka qaba dhaawaca beerka uma baahna inay hagaajiyaan qiyaasta.Soo-gaadhista Enpagliflozin ayaa kor u kacday bukaannada qaba dhaawaca beerka ee daran.Waayo-aragnimada daaweynta bukaannada qaba dhaawaca beerka daran waa mid xaddidan, sidaas darteed, laguma talinayo qaybtan dadweynaha.